BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7007509)

  • 21. Antibody avidity for native DNA in lupus nephritis.
    Koyama A; Narita M; Tojo S
    Contrib Nephrol; 1975; 4():72-82. PubMed ID: 1235100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).
    Harkiss GD; Brown DL
    Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating immune complexes by PEG precipitation combined with ELISA.
    Ohlson S; Zetterstrand K
    J Immunol Methods; 1985 Feb; 77(1):87-93. PubMed ID: 3973400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
    Smeenk R; van der Lelij G; Aarden L
    Clin Exp Immunol; 1982 Sep; 49(3):603-10. PubMed ID: 6756723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of anti-native DNA antibodies by immunofluorescence on Crithidia luciliae. Correlation between renal involvement and the presence of high-avidity anti-native DNA antibodies in lupic disease].
    Meyer O; Borda-Iriarte O; Haïm T; Ryckewaert A
    Presse Med; 1984 Dec; 13(46):2801-5. PubMed ID: 6240645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunology of DNA. IV. Quantitative aspects of the Farr assay.
    Aarden LA; Lakmaker F; De Groot ER
    J Immunol Methods; 1976; 11(2):153-63. PubMed ID: 932447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
    Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
    J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus.
    Egido J; Sánchez Crespo M; Lahoz C; García R; López-Trascasa M; Hernando L
    Ann Rheum Dis; 1980 Aug; 39(4):312-7. PubMed ID: 6969064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of circulating immune complexes in lupus erythematosus by precipitation test with polyethylene glycol and complement consumption test (author's transl)].
    Anan S; Renoux ML
    Ann Dermatol Venereol; 1977; 104(6-7):446-52. PubMed ID: 303493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of DNA in polyethylene glycol precipitated immune complexes from sera of patients with systemic lupus erythematosus.
    Ikebe K; Gupta RC; Tan EM
    Clin Exp Immunol; 1983 Oct; 54(1):169-77. PubMed ID: 6616966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorimetric method for the detection of anti-DNA antibodies in serum.
    Spilberg I; Gallacher A; Mandell B; Hahn B; Mehta J
    Am J Med Sci; 1976; 272(1):83-8. PubMed ID: 134637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.
    Bruneau CD; Edmonds JP; Hughes GR; Aarden L
    Clin Exp Immunol; 1977 Jun; 28(3):433-6. PubMed ID: 302166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
    Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
    Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fluorescence sedimentation assay for dsDNA antibodies.
    Duus K; Draborg AH; Güven E; Moreno YM; Jacobsen S; Nielsen CT; Houen G
    Scand J Clin Lab Invest; 2017 Oct; 77(6):465-471. PubMed ID: 28678535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial purification of anti-DNA antibodies from systemic lupus erythematosus serum by dye-ligand chromatography.
    Pollard KM; Webb J
    J Immunol Methods; 1982 Oct; 54(1):81-94. PubMed ID: 6982949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.
    Pisetsky DS; Shaffer R; Armstrong DD; Spencer DM
    Clin Immunol; 2021 Oct; 231():108848. PubMed ID: 34492381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.